Home › RICHARD-ALLAN SCIENTIFIC COMPANY › Epredia

Epredia

RICHARD-ALLAN SCIENTIFIC COMPANY · Model Harris Hematoxylin Acidified (Series S) · UDI-DI 00673693228428

510(k) clearances

Adverse events

Recalls

Facilities

Description

Harris hematoxylins are ready to use and available in your choice of acidified and non-acidified formulations. Both formulations are used regressively, where the nuclear chromatin and cytoplasm are overstained and then the excess stain is removed through the process of differentiation. Harris hematoxylins will provide familiar, consistent, well-delineated results.

Query this across every FDA database — by API.

Linked GUDID · 510(k)/PMA · MAUDE · recalls · establishments. Free tier, no card required.

Get your free API key Read the docs

Data compiled from public U.S. FDA sources (GUDID, 510(k)/PMA, MAUDE, recalls, establishment registration). Adverse-event reports are unverified and do not establish causation. Informational only — not medical, clinical, or regulatory advice.